Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd
(NASDAQ:SMTI), OsStic(R) and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually(1); arrangement leverages Sanara's existing call points and commercial infrastructure, and complements Sanara's existing surgical portfolio FORT WORTH, TX, Jan. 21, 2025 (GLOBE NEWSWIRE) — Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the […]